Clinical Trials

50 trials registered for Beta-thalassemia

Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients
NCT05745532Early Phase 1Shenzhen Hemogen
Recruiting
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
NCT05635266N/ASanguine Biosciences
Recruiting
Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells
NCT05442346N/ABioray Laboratories
Suspended
Benefits of Nigella Sativa in Children With Beta Thalassemia Major
NCT02816957Early Phase 1Tanta University
Unknown
Gene Therapy for Transfusion Dependent Beta-thalassemia
NCT02453477Phase 1/2IRCCS San Raffaele
Unknown
Interferon and Ribavirin Treatment in Patients With Hemoglobinopathies
NCT00887081Phase 4Azienda Ospedaliera V. Cervello
Unknown
Study on the Effect of Different Risk Factors on the Growth Parameters of Thalassemic Patients in Assiut (AUCH)
NCT05303506N/AAssiut University
Unknown
Thalassemic Iron Overload Cardiomyopathy is Ameliorated by Taurine Supplementation
NCT04291352N/AUniversity Health Network, Toronto
Unknown
Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin.
NCT01624038Phase 2/3Ain Shams University
Unknown
Unrelated Umbilical Cord Blood Following HLA-haploidentical Hematopoietic Stem Cell Transplantation in Patients With β-thalassemia Major
NCT02126046N/ANanfang Hospital, Southern Medical University
Unknown